(Q48088375)

8 February 2018

title

Abatacept treatment reduces disease activity in early primary Sjögren's syndrome (open-label proof of concept ASAP study). (English)

1 reference

8 February 2018

1 reference

P M Meiners

1

1 reference

8 February 2018

A Vissink

2

1 reference

8 February 2018

F G M Kroese

3

1 reference

8 February 2018

F K L Spijkervet

4

1 reference

8 February 2018

N Sillevis Smitt-Kamminga

5

1 reference

8 February 2018

W H Abdulahad

6

1 reference

8 February 2018

J Bulthuis-Kuiper

7

1 reference

8 February 2018

E Brouwer

8

1 reference

8 February 2018

S Arends

9

1 reference

8 February 2018

H Bootsma

10

1 reference

8 February 2018

language of work or name

English

0 references

publication date

28 January 2014

1 reference

8 February 2018

Annals of the Rheumatic Diseases

published in

1 reference

8 February 2018

volume

73

1 reference

8 February 2018

issue

7

1 reference

8 February 2018

page(s)

1393-1396

1 reference

8 February 2018

Topical and systemic medications for the treatment of primary Sjögren's syndrome.

cites work

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204653

Costimulatory B7 molecules in the pathogenesis of infectious and autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204653

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2012.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204653

Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204653

EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204653

EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204653

Accurate detection of changes in disease activity in primary Sjögren's syndrome by the European League Against Rheumatism Sjögren's Syndrome Disease Activity Index

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204653

Responsiveness of disease activity indices ESSPRI and ESSDAI in patients with primary Sjögren's syndrome treated with rituximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204653

EULAR Sjogren's Syndrome Disease Activity Index (ESSDAI) is sensitive to show efficacy of rituximab treatment in a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204653

Sialometry and sialochemistry: a non-invasive approach for diagnosing Sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204653

The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204653

The MOS 36-ltem Short-Form Health Survey (SF-36)

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204653

Long-term safety, efficacy and inhibition of radiographic progression with abatacept treatment in patients with rheumatoid arthritis and an inadequate response to methotrexate: 3-year results from the AIM trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204653

Longterm safety and efficacy of abatacept through 5 years of treatment in patients with rheumatoid arthritis and an inadequate response to tumor necrosis factor inhibitor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204653

Evaluation of histologic, serologic, and clinical changes in response to abatacept treatment of primary Sjögren’s syndrome: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204653

European League Against Rheumatism Sjögren's Syndrome Disease Activity Index and European League Against Rheumatism Sjögren's Syndrome Patient-Reported Index: A Complete Picture of Primary Sjögren's Syndrome Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204653

10.1136/ANNRHEUMDIS-2013-204653

21 January 2018

Identifiers

DOI

1 reference

8 February 2018

1 reference

8 February 2018